Evidence map›Paper›PMID 29463911›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Disruption of lipid-raft localized Gα

Harinder Singh, Nathan Wray, Jeffrey M Schappi, Mark M Rasenick

RetractedErratum issuedOpen access · bronzeAbstract readRetracted Publication
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Serotonin Signaling through Lipid Membranes.ACS chemical neuroscience · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. GαFrontiers in pharmacology · 2022
    Review
  10. Antidepressants Produce Persistent GMolecular pharmacology · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Histone deacetylase inhibitor MPT0B291 suppresses Glioma GrowthInternational journal of biological sciences · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Harinder SinghDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Nathan WrayDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Jeffrey M SchappiDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Mark M RasenickDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, 60612, USA. raz@uic.edu.
University of Illinois Chicago · US

Funding

Pilot Project Program P50AA022538 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Elizabeth J Glover · 2015 to 2026
$21.3M
Training in the Neuroscience of Mental HealthT32MH067631 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RASENICK, MARK M. · 2004 to 2024
$4.8M
Mechanism of Action for n-3 PUFA antidepressant propertiesR01AT009169 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RASENICK, MARK M. · 2015 to 2018
$1.5M
Lipid raft localization of Gs: a biomarker for depression and therapeutic responseI01BX001149 · VA · JESSE BROWN VA MEDICAL CENTER · PI RASENICK, MARK M. · 2012 to 2024
–
BLRD Research Career Scientist Award ApplicationIK6BX004475 · VA · JESSE BROWN VA MEDICAL CENTER · PI MARK M. RASENICK · 2019 to 2026
–
BLRD VA I01 BX001149BLRD VA IK6 BX004475NCCIH NIH HHS R01 AT009169NIAAA NIH HHS P50 AA022538NIMH NIH HHS T32 MH067631
6 · The paper itself

Abstract

Current antidepressant therapies meet with variable therapeutic success and there is increasing interest in therapeutic approaches not based on monoamine signaling. Histone deacetylase 6 (HDAC6), which also deacetylates α-tubulin shows altered expression in mood disorders and HDAC6 knockout mice mimic traditional antidepressant treatments. Nonetheless, a mechanistic understanding for HDAC6 inhibitors in the treatment of depression remains elusive. Previously, we have shown that sustained treatment of rats or glioma cells with several antidepressants translocates Gα

Indexed as

AcetylationAcetyltransferasesAnimalsAntidepressive Agents, TricyclicBrain-Derived Neurotrophic FactorCell Line, TumorCitalopramCyclic AMPCyclic AMP Response Element-Binding ProteinGTP-Binding Protein alpha Subunits, GsHistone Deacetylase InhibitorsHydroxamic AcidsImipramineIndolesMembrane MicrodomainsRatsAcetyltransferasesAntidepressive Agents, TricyclicBdnf protein, ratBrain-Derived Neurotrophic FactorCitalopramCyclic AMPCyclic AMP Response Element-Binding ProteinGTP-Binding Protein alpha Subunits, GsHistone Deacetylase InhibitorsHydroxamic AcidsImipramineIndolesRNA, Small InterferingSelective Serotonin Reuptake Inhibitorstubastatin ATubulin

Identifiers

PMID29463911
PMCPMC5983546
OpenAlexW2793827288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.